Date: 18 – 20 October
Location: Tokyo Big Sight, 3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan
Asia’s leading forum on pharmacovigilance, regulatory science, and the role of AI in advancing drug safety, bringing together regulators, sponsors, and industry across Japan, APAC, and globally.
This year’s edition introduces a dedicated English-language track to support cross-border participation.
ArisGlobal joins as Gold Sponsor and exhibitor at Booths #43 and #44.
Visit the team across the three-day programme to discuss our work with PV and regulatory leaders across APAC.
Date: 19 Oct
Time: 13:00 – 14:00
Location: 701&702,
Speakers:
- Ken Kubota, Vice President, Global Customer Excellence, ArisGlobal
- Dr. Jiang Dapeng, Solution Consultant, APAC, ArisGlobal
From Generative AI to Agentic AI: Transforming Drug Safety and Regulatory Affairs with NavaX
Japanese pharmaceutical companies are navigating growing data volumes, evolving regulatory expectations, and increasing pressure to improve efficiency without compromising quality, transparency or patient safety.
This session will explore how organizations can move beyond AI experimentation to operationalize AI across Safety and Regulatory Affairs. See NavaX Agents in action across regulatory intelligence, safety reporting, signal management and advanced case intake — connecting information, reducing complexity and enabling faster, better-informed decisions.
Built for the realities of the Japanese market and validated with real-world Japanese-language data, NavaX provides a practical path to scaling AI and building more intelligent, future-ready operations.
